A Double-Blind Comparative Immunotypic Study Between Two Institutions Phenotyping Non-Hodgkin’s Lymphomas
Authors:
Open Access
- 1 April 1987
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 87 (4) , 478-484
Abstract
To establish the feasibility of immunotyping specimens transported over great distance, the University of Arizona and the Cleveland Clinic exchanged 39 lymphoma cases (26 B-cell, 13 T-cell cases) via air express for phenotyping. They were exchanged with the use of glass slides with adherent snap-frozen sections. The method involved immunohistochemistry using a common battery of 20 antibodies directed at B- and T-cell antigens. Using similar, but not identical, methods and reagents, cases were assayed before and after transport. Results were generated as paired determinations in a double-blind fashion (1,338 total determinations, 669 paired determinations/669 antigens). Using “pretransport” values as the baseline, there was subsequent agreement with baseline in 624 of 669 antigenic determinations (93.3%) and disagreement in 45 (6.7%). Interinstitutional agreement was 94% for T-antigens (Leu-1–7, 9) and 93% for B-antigens (K, λ; IgM, G, A, D; B1, B2, B4, L14; J5, common acute lymphocyte leukemia antigen [CALLA]; Ia). In spite of 6.7% disagreement, there was agreement of overall phenotypic profile (e.g., B vs. T and subset stage) in all 39 cases. This is because discrepancies were isolated and the battery offset undue reliance on a single antigen. The disagreements relate mainly to certain B-antigens: CALLA/J5 (eight disagreements) and B1 and B2 (six and five disagreements, respectively). T-antigen disagreements were more sporadic (e.g., Leu-5 [three disagreements]). These discrepancies may relate to antigen loss with transport, variable antigen density or antibody avidity, methodologic differences, quality of reagents, or differences of phenotype interpretation. A further exchange of the 45 disagreement slides indicated that difference of observer interpretation was a minor factor (3 of 45). In conclusion, the authors’ study demonstrates a high degree of immunotype reproducibility (~93%), suggesting promise for institutions doing collaborative lymphoma studies.Keywords
This publication has 8 references indexed in Scilit:
- Immunophenotypes in “well-differentiated” lymphoproliferative disorders, with emphasis on small lymphocytic lymphomaHuman Pathology, 1986
- Chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisone alone or with levamisole or with levamisole plus BCG for malignant lymphoma: a Southwest Oncology Group Study.Journal of Clinical Oncology, 1985
- Peripheral T-Cell Lymphoma: Aggressive Disease with Heterogeneous ImmunotypesAmerican Journal of Clinical Pathology, 1985
- MULTIINSTITUTION STUDY OF NON-HODGKINS LYMPHOMAS USING FROZEN SECTION IMMUNOPEROXIDASE - THE SOUTHEASTERN CANCER STUDY-GROUP EXPERIENCE1984
- THE IMMUNOLOGICAL AND CLINICOPATHOLOGIC HETEROGENEITY OF CUTANEOUS LYMPHOMAS OTHER THAN MYCOSIS-FUNGOIDES1983
- EXPRESSION OF A T-CELL ANTIGEN (LEU-1) BY B-CELL LYMPHOMAS1983
- IMMUNOHISTOLOGIC CELLULAR PHENOTYPES OF LYMPHOPROLIFERATIVE DISORDERS - COMPREHENSIVE EVALUATION OF 564 CASES INCLUDING 257 NON-HODGKINS LYMPHOMAS CLASSIFIED BY THE INTERNATIONAL WORKING FORMULATION1983
- Immunohistochemistry of Fresh-frozen Lymphoid Tissue with the Direct Immunoperoxidase TechnicAmerican Journal of Clinical Pathology, 1981